ArticleBMC infectious diseases2026
Prevalence and characteristics of persistent symptoms following hospitalization for COVID-19: a cross-sectional follow-up study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough coronavirus disease 2019 (COVID-19) primarily presents as an acute respiratory infection, many patients continue to experience symptoms after the acute phase of the disease. Early persistent symptoms during the post-acute recovery period may adversely affect functional recovery and quality of life. This study aimed to evaluate persistent symptoms in hospitalized COVID-19 patients following completion of the quarantine period.
methodsThis retrospective longitudinal follow-up study evaluated hospitalized COVID-19 patients after completion of quarantine/isolation to determine the prevalence and characteristics of persistent symptoms. Descriptive statistics and chi-square or Fisher's exact tests were used, with p < 0.05 considered statistically significant.
resultsA total of 180 patients were included, with a mean age of 50.63 ± 16.90 years, and 52.8% were female. At initial presentation, the most common symptoms were weakness (53.9%), diffuse body/muscle/joint pain (48.9%), cough (48.3%), fever (41.1%), loss of taste and smell (30.0%), headache (28.3%), and dyspnea (24.4%). Persistent symptoms after the quarantine period were observed in 64.9% of patients. The most common persistent symptoms were cough (28.9%), weakness (28.9%), diffuse body/muscle/joint pain (20.0%), loss of taste and smell (13.3%), dyspnea (12.8%), fatigue/exhaustion (12.8%), and headache (11.1%). Significant reductions were observed in several symptoms after the acute phase, including fever, sore throat, headache, diarrhea, and abdominal pain (p < 0.05).
conclusionsPersistent symptoms were frequently observed during the early post-acute recovery period in hospitalized COVID-19 patients. Respiratory complaints, fatigue, weakness, and musculoskeletal symptoms remained common after the acute infectious period. These findings emphasize the importance of post-discharge follow-up and supportive care strategies in patients recovering from COVID-19. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.